Cronos Group Inc vs Nasdaq100 ETF — how do they compare? Cronos Group Inc trades at $3.07 (market cap $1.14B), while Nasdaq100 ETF trades at $726.12. Which is the better fit depends on your goals.
| CRON | QQQ | |
|---|---|---|
Market Cap | $1.14B | — |
Sector | Health | — |
52-Week High | $3.27 | $746.16 |
52-Week Low | $2.30 | $558.34 |
Enterprise Value | $341.13M | — |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.00, down 3.23% today, with a bullish technical signal from moving averages. The company showed strong Q2 2026 performance with 58% YoY revenue growth and earnings beat, though recent quarters were mixed. Valuation metrics include P/E of 16.21 and P/S of 6.55, while profitability improved with 45.86% gross margin. Analyst consensus is mixed with 20% buy, 60% hold ratings.
Outlook remains positive due to international expansion and strong product positioning, particularly in Canada and Europe. Key risks include competitive pressures and cash flow volatility from aggressive investing. The stock presents growth potential but requires monitoring of execution and market conditions.
QQQ trades at $720.85, down 0.3% with a bullish technical signal from moving averages while oscillators show neutral momentum. The ETF shows strong institutional interest with recent purchases by Ferguson Shapiro LLC and Avior Wealth Management. Analyst sentiment is divided with equal buy and sell ratings, reflecting uncertainty about the tech-heavy Nasdaq's continued rally in H2 2026.
The outlook remains cautiously optimistic given historical momentum trends and Federal Reserve policy expectations, though risks include expense ratio concerns versus cheaper alternatives like QQQM and potential volatility from concentrated tech exposure. Key support sits at $715 with resistance at $724.
Trailing returns across standard periods
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →The ETF is designed to track the performance of the securities and the stocks in the NASDAQ-100 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on QQQ →